GPFA
ANVS icon

Game Plan Financial Advisors’s Annovis Bio ANVS Stock Holding History

Game Plan Financial Advisors’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-200
Closed -$300 – 358
2025
Q1 		$300 Hold
200
– – ﹤0.01% 326
2024
Q4 		$1K Hold
200
– – ﹤0.01% 313
2024
Q3 		$1.61K Hold
200
– – ﹤0.01% 317
2024
Q2 		$1.15K Hold
200
– – ﹤0.01% 323
2024
Q1 		$2.38K Hold
200
– – ﹤0.01% 337
2023
Q4 		$3.74K Buy
+200
New +$1.77K ﹤0.01% 309
2021
Q3 		– Sell
-2,700
Closed -$231K – 108
2021
Q2 		$231K Buy
+2,700
New +$125K 0.14% 85

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Game Plan Financial Advisors's ANVS Position: Q2 2025 in Review

Game Plan Financial Advisors sold out of Annovis Bio (ANVS) in Q2 2025, closing a stake of 200 shares — an estimated $300 sold.

Game Plan Financial Advisors first reported a position in ANVS in Q2 2021 and held it in 7 quarters. The position peaked at $231K in Q2 2021. 42 funds tracked by Wall St. Rank hold ANVS as of Q2 2025.

  • Game Plan Financial Advisors reported no remaining Annovis Bio position as of Q2 2025 after selling out during the quarter.
  • Game Plan Financial Advisors sold 200 Annovis Bio shares in Q2 2025, an estimated $300.
  • Game Plan Financial Advisors first reported a position in Annovis Bio in Q2 2021 and held it in 7 quarters.
  • Game Plan Financial Advisors's Annovis Bio position peaked at $231K in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2025.

Based on Game Plan Financial Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.